Intensity Therapeutics closes full exercise of IPO over-allotment, raises $22.425M gross

INTENSITY THERAPEUTICS, INC.

Total gross proceeds from upsized IPO and full over-allotment exercise: $22.425 million.
Underwriters exercised option to purchase 585,000 additional shares at $5.00, adding $2.925M gross.
Net proceeds to Intensity after underwriting discounts and expenses: approximately $18.9 million.
Joint book-running managers: The Benchmark Company and Freedom Capital Markets.
Closing and full exercise announced July 10, 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.